0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Benign Prostatic Hyperplasia Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-6O8897
Home | Market Reports | Health| Men s Health
China Benign Prostatic Hyperplasia Devices Market Report Forecast 2021 2027
BUY CHAPTERS

Global Benign Prostatic Hyperplasia Devices Market Research Report 2025

Code: QYRE-Auto-6O8897
Report
August 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Benign Prostatic Hyperplasia Devices Market Size

The global market for Benign Prostatic Hyperplasia Devices was valued at US$ 413 million in the year 2024 and is projected to reach a revised size of US$ 546 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Benign Prostatic Hyperplasia Devices Market

Benign Prostatic Hyperplasia Devices Market

Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications

Report Scope

This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasia Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasia Devices.
The Benign Prostatic Hyperplasia Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Benign Prostatic Hyperplasia Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Benign Prostatic Hyperplasia Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Benign Prostatic Hyperplasia Devices Market Report

Report Metric Details
Report Name Benign Prostatic Hyperplasia Devices Market
Accounted market size in year US$ 413 million
Forecasted market size in 2031 US$ 546 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Transurethral Resection of the Prostate (TURP)
  • Transurethral Microwave Therapy (TUMT)
  • Transurethral Needle Ablation of the Prostate (TUNA)
  • Laser Surgery
  • Prostatic Stenting
  • Others
Segment by Application
  • Hospitals and Clinics
  • Ambulatory Surgical Centers(ASC)
  • Home
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lumenis, Olympus corporation, Urologix, Boston Scientific corporation, Lisa Laser, Medifocus, Neotrac, ProArc Medical LTD, Urotech GMBH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Benign Prostatic Hyperplasia Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Benign Prostatic Hyperplasia Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Benign Prostatic Hyperplasia Devices Market growing?

Ans: The Benign Prostatic Hyperplasia Devices Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Benign Prostatic Hyperplasia Devices Market size in 2031?

Ans: The Benign Prostatic Hyperplasia Devices Market size in 2031 will be US$ 546 million.

Who are the main players in the Benign Prostatic Hyperplasia Devices Market report?

Ans: The main players in the Benign Prostatic Hyperplasia Devices Market are Lumenis, Olympus corporation, Urologix, Boston Scientific corporation, Lisa Laser, Medifocus, Neotrac, ProArc Medical LTD, Urotech GMBH

What are the Application segmentation covered in the Benign Prostatic Hyperplasia Devices Market report?

Ans: The Applications covered in the Benign Prostatic Hyperplasia Devices Market report are Hospitals and Clinics, Ambulatory Surgical Centers(ASC), Home, Others

What are the Type segmentation covered in the Benign Prostatic Hyperplasia Devices Market report?

Ans: The Types covered in the Benign Prostatic Hyperplasia Devices Market report are Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Surgery, Prostatic Stenting, Others

1 Benign Prostatic Hyperplasia Devices Market Overview
1.1 Product Definition
1.2 Benign Prostatic Hyperplasia Devices by Type
1.2.1 Global Benign Prostatic Hyperplasia Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transurethral Resection of the Prostate (TURP)
1.2.3 Transurethral Microwave Therapy (TUMT)
1.2.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.5 Laser Surgery
1.2.6 Prostatic Stenting
1.2.7 Others
1.3 Benign Prostatic Hyperplasia Devices by Application
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Global Benign Prostatic Hyperplasia Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hyperplasia Devices Revenue 2020-2031
1.4.2 Global Benign Prostatic Hyperplasia Devices Sales 2020-2031
1.4.3 Global Benign Prostatic Hyperplasia Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Benign Prostatic Hyperplasia Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Benign Prostatic Hyperplasia Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Product Type & Application
2.7 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Date of Enter into This Industry
2.8 Global Benign Prostatic Hyperplasia Devices Market Competitive Situation and Trends
2.8.1 Global Benign Prostatic Hyperplasia Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Benign Prostatic Hyperplasia Devices Players Market Share by Revenue
2.8.3 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Benign Prostatic Hyperplasia Devices Market Scenario by Region
3.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2020-2031
3.2.1 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2020-2025
3.2.2 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2026-2031
3.3 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2020-2031
3.3.1 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2020-2025
3.3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2026-2031
3.4 North America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.4.1 North America Benign Prostatic Hyperplasia Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Benign Prostatic Hyperplasia Devices Sales by Country (2020-2031)
3.4.3 North America Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.5.1 Europe Benign Prostatic Hyperplasia Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Benign Prostatic Hyperplasia Devices Sales by Country (2020-2031)
3.5.3 Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Benign Prostatic Hyperplasia Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Benign Prostatic Hyperplasia Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Benign Prostatic Hyperplasia Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.7.1 Latin America Benign Prostatic Hyperplasia Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2020-2031)
3.7.3 Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Benign Prostatic Hyperplasia Devices Sales by Type (2020-2031)
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Type (2020-2025)
4.1.2 Global Benign Prostatic Hyperplasia Devices Sales by Type (2026-2031)
4.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2020-2031)
4.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2020-2031)
4.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2020-2025)
4.2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2026-2031)
4.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2020-2031)
4.3 Global Benign Prostatic Hyperplasia Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Benign Prostatic Hyperplasia Devices Sales by Application (2020-2031)
5.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Application (2020-2025)
5.1.2 Global Benign Prostatic Hyperplasia Devices Sales by Application (2026-2031)
5.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2020-2031)
5.2 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2020-2031)
5.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2020-2025)
5.2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Application (2026-2031)
5.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2020-2031)
5.3 Global Benign Prostatic Hyperplasia Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lumenis
6.1.1 Lumenis Company Information
6.1.2 Lumenis Description and Business Overview
6.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lumenis Benign Prostatic Hyperplasia Devices Product Portfolio
6.1.5 Lumenis Recent Developments/Updates
6.2 Olympus corporation
6.2.1 Olympus corporation Company Information
6.2.2 Olympus corporation Description and Business Overview
6.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.2.5 Olympus corporation Recent Developments/Updates
6.3 Urologix
6.3.1 Urologix Company Information
6.3.2 Urologix Description and Business Overview
6.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Urologix Benign Prostatic Hyperplasia Devices Product Portfolio
6.3.5 Urologix Recent Developments/Updates
6.4 Boston Scientific corporation
6.4.1 Boston Scientific corporation Company Information
6.4.2 Boston Scientific corporation Description and Business Overview
6.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolio
6.4.5 Boston Scientific corporation Recent Developments/Updates
6.5 Lisa Laser
6.5.1 Lisa Laser Company Information
6.5.2 Lisa Laser Description and Business Overview
6.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolio
6.5.5 Lisa Laser Recent Developments/Updates
6.6 Medifocus
6.6.1 Medifocus Company Information
6.6.2 Medifocus Description and Business Overview
6.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medifocus Benign Prostatic Hyperplasia Devices Product Portfolio
6.6.5 Medifocus Recent Developments/Updates
6.7 Neotrac
6.7.1 Neotrac Company Information
6.7.2 Neotrac Description and Business Overview
6.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Neotrac Benign Prostatic Hyperplasia Devices Product Portfolio
6.7.5 Neotrac Recent Developments/Updates
6.8 ProArc Medical LTD
6.8.1 ProArc Medical LTD Company Information
6.8.2 ProArc Medical LTD Description and Business Overview
6.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolio
6.8.5 ProArc Medical LTD Recent Developments/Updates
6.9 Urotech GMBH
6.9.1 Urotech GMBH Company Information
6.9.2 Urotech GMBH Description and Business Overview
6.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolio
6.9.5 Urotech GMBH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Benign Prostatic Hyperplasia Devices Industry Chain Analysis
7.2 Benign Prostatic Hyperplasia Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Benign Prostatic Hyperplasia Devices Production Mode & Process Analysis
7.4 Benign Prostatic Hyperplasia Devices Sales and Marketing
7.4.1 Benign Prostatic Hyperplasia Devices Sales Channels
7.4.2 Benign Prostatic Hyperplasia Devices Distributors
7.5 Benign Prostatic Hyperplasia Devices Customer Analysis
8 Benign Prostatic Hyperplasia Devices Market Dynamics
8.1 Benign Prostatic Hyperplasia Devices Industry Trends
8.2 Benign Prostatic Hyperplasia Devices Market Drivers
8.3 Benign Prostatic Hyperplasia Devices Market Challenges
8.4 Benign Prostatic Hyperplasia Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Benign Prostatic Hyperplasia Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Benign Prostatic Hyperplasia Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Benign Prostatic Hyperplasia Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Benign Prostatic Hyperplasia Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Benign Prostatic Hyperplasia Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Benign Prostatic Hyperplasia Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Benign Prostatic Hyperplasia Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Benign Prostatic Hyperplasia Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Benign Prostatic Hyperplasia Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Benign Prostatic Hyperplasia Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Benign Prostatic Hyperplasia Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Benign Prostatic Hyperplasia Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Benign Prostatic Hyperplasia Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Benign Prostatic Hyperplasia Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Benign Prostatic Hyperplasia Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Benign Prostatic Hyperplasia Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Benign Prostatic Hyperplasia Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Benign Prostatic Hyperplasia Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Benign Prostatic Hyperplasia Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Benign Prostatic Hyperplasia Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Benign Prostatic Hyperplasia Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Benign Prostatic Hyperplasia Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Benign Prostatic Hyperplasia Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Benign Prostatic Hyperplasia Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Lumenis Company Information
 Table 71. Lumenis Description and Business Overview
 Table 72. Lumenis Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Lumenis Benign Prostatic Hyperplasia Devices Product
 Table 74. Lumenis Recent Developments/Updates
 Table 75. Olympus corporation Company Information
 Table 76. Olympus corporation Description and Business Overview
 Table 77. Olympus corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Olympus corporation Benign Prostatic Hyperplasia Devices Product
 Table 79. Olympus corporation Recent Developments/Updates
 Table 80. Urologix Company Information
 Table 81. Urologix Description and Business Overview
 Table 82. Urologix Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Urologix Benign Prostatic Hyperplasia Devices Product
 Table 84. Urologix Recent Developments/Updates
 Table 85. Boston Scientific corporation Company Information
 Table 86. Boston Scientific corporation Description and Business Overview
 Table 87. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product
 Table 89. Boston Scientific corporation Recent Developments/Updates
 Table 90. Lisa Laser Company Information
 Table 91. Lisa Laser Description and Business Overview
 Table 92. Lisa Laser Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Lisa Laser Benign Prostatic Hyperplasia Devices Product
 Table 94. Lisa Laser Recent Developments/Updates
 Table 95. Medifocus Company Information
 Table 96. Medifocus Description and Business Overview
 Table 97. Medifocus Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Medifocus Benign Prostatic Hyperplasia Devices Product
 Table 99. Medifocus Recent Developments/Updates
 Table 100. Neotrac Company Information
 Table 101. Neotrac Description and Business Overview
 Table 102. Neotrac Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Neotrac Benign Prostatic Hyperplasia Devices Product
 Table 104. Neotrac Recent Developments/Updates
 Table 105. ProArc Medical LTD Company Information
 Table 106. ProArc Medical LTD Description and Business Overview
 Table 107. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product
 Table 109. ProArc Medical LTD Recent Developments/Updates
 Table 110. Urotech GMBH Company Information
 Table 111. Urotech GMBH Description and Business Overview
 Table 112. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Urotech GMBH Benign Prostatic Hyperplasia Devices Product
 Table 114. Urotech GMBH Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Benign Prostatic Hyperplasia Devices Distributors List
 Table 118. Benign Prostatic Hyperplasia Devices Customers List
 Table 119. Benign Prostatic Hyperplasia Devices Market Trends
 Table 120. Benign Prostatic Hyperplasia Devices Market Drivers
 Table 121. Benign Prostatic Hyperplasia Devices Market Challenges
 Table 122. Benign Prostatic Hyperplasia Devices Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Benign Prostatic Hyperplasia Devices
 Figure 2. Global Benign Prostatic Hyperplasia Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Benign Prostatic Hyperplasia Devices Market Share by Type: 2024 & 2031
 Figure 4. Transurethral Resection of the Prostate (TURP) Product Picture
 Figure 5. Transurethral Microwave Therapy (TUMT) Product Picture
 Figure 6. Transurethral Needle Ablation of the Prostate (TUNA) Product Picture
 Figure 7. Laser Surgery Product Picture
 Figure 8. Prostatic Stenting Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Benign Prostatic Hyperplasia Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Benign Prostatic Hyperplasia Devices Market Share by Application: 2024 & 2031
 Figure 12. Hospitals and Clinics
 Figure 13. Ambulatory Surgical Centers(ASC)
 Figure 14. Home
 Figure 15. Others
 Figure 16. Global Benign Prostatic Hyperplasia Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Benign Prostatic Hyperplasia Devices Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Benign Prostatic Hyperplasia Devices Sales (2020-2031) & (K Units)
 Figure 19. Global Benign Prostatic Hyperplasia Devices Average Price (USD/Unit) & (2020-2031)
 Figure 20. Benign Prostatic Hyperplasia Devices Report Years Considered
 Figure 21. Benign Prostatic Hyperplasia Devices Sales Share by Manufacturers in 2024
 Figure 22. Global Benign Prostatic Hyperplasia Devices Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Benign Prostatic Hyperplasia Devices Players: Market Share by Revenue in Benign Prostatic Hyperplasia Devices in 2024
 Figure 24. Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Benign Prostatic Hyperplasia Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2020-2031)
 Figure 27. North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2020-2031)
 Figure 31. Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2020-2031)
 Figure 39. China Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Benign Prostatic Hyperplasia Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Benign Prostatic Hyperplasia Devices by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Benign Prostatic Hyperplasia Devices by Type (2020-2031)
 Figure 61. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Benign Prostatic Hyperplasia Devices by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Benign Prostatic Hyperplasia Devices by Application (2020-2031)
 Figure 64. Global Benign Prostatic Hyperplasia Devices Price (USD/Unit) by Application (2020-2031)
 Figure 65. Benign Prostatic Hyperplasia Devices Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Testosterone Injectable Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22D16731
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Testosterone Replacement Injectables Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5N17091
Fri Nov 07 00:00:00 UTC 2025

Add to Cart

Global Circumcision Suture Device Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-30Q16813
Tue Nov 04 00:00:00 UTC 2025

Add to Cart

Global Disposable Prostate Biopsy Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-35J17156
Mon Nov 03 00:00:00 UTC 2025

Add to Cart